Author: CSRA
Effective Aug. 1, 2018, North Carolina Medicaid will make a change to the N.C. Medicaid and N.C. Health Choice Preferred Drug List (PDL) in the Antihyperkinesis/Attention Deficit Hyperactivity Disorder (ADHD) class.
Ritalin tablets will be moved to non-preferred status. Generic methylphenidate tablets will remain preferred. Concerta tablets will be moved back to non-preferred status. Concerta was moved to preferred status Jan. 15, 2018, related to shortages in the ADHD class. Aptensio XR will remain preferred.
CSRA, 1-800-688-6696